Simon Property Group Inc. Stock Rises Tuesday, Outperforms Market

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Simon Property Group Inc. Stock Rises Tuesday, Outperforms Market

5:23 pm ET November 15, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Simon Property Group Inc. (SPG) rose 2.24% to $120.16 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.87% to 3,991.73 and the Dow Jones Industrial Average rising 0.17% to 33,592.92. Simon Property Group Inc. closed $50.96 below its 52-week high ($171.12), which the company achieved on November 18th.

The stock outperformed some of its competitors Tuesday, as Alexandria Real Estate Equities Inc. (ARE) rose 1.66% to $149.82 and Vornado Realty Trust (VNO) rose 0.68% to $25.11. Trading volume (1.7 M) remained 434,885 below its 50-day average volume of 2.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2022.

(END) Dow Jones Newswires

November 15, 2022 17:23 ET (22:23 GMT)